{"data":{"id":"us-ne/neb.-rev.-stat.-71-9603","jurisdiction":"us-ne","citation":"Neb. Rev. Stat. § 71-9603","heading":"Neb. Rev. Stat. § 71-9603","body":"To be an eligible patient under the Investigational Drug Use Act, a person shall:\n\n(1) Have an advanced illness, attested by the person's treating physician;\n\n(2) Have considered all other treatment options approved by the United States Food and Drug Administration at the time;\n\n(3) Have a recommendation from his or her treating physician for an investigational drug, biological product, or device;\n\n(4) Give written, informed consent for the use of the investigational drug, biological product, or device;\n\n(5) Have documentation from his or her treating physician that he or she meets the requirements of the act; and\n\n(6) Not be a patient receiving inpatient treatment in a hospital licensed pursuant to the Health Care Facility Licensure Act.","path":["NE Code","Chapter 71"],"source_url":"https://nebraskalegislature.gov/laws/statutes.php?statute=71-9603","current_through":"2026-08-14","vintage":"open-us-law v2026.08, retrieved 2026-09-14","retrieved_at":"2026-09-14T18:32:21Z","sha256":"32be1ea7e4bd706bb8c5025187721c148fc98324d5286ea3d50d2fc739a3b1e5","source_id":"us-ne","stale":false,"prev":"us-ne/neb.-rev.-stat.-71-9602","next":"us-ne/neb.-rev.-stat.-71-9604"},"notice":"GroundRules: Original legal text. Not legal advice."}